LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

Search

Fulgent Genetics Inc

Avatud

SektorTervishoid

21.39 0.47

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

20.65

Max

21.41

Põhinäitajad

By Trading Economics

Sissetulek

-5.7M

-12M

Müük

-2.8M

73M

Aktsiakasum

0.04

Kasumimarginaal

-16.197

Töötajad

1,313

EBITDA

-2M

-12M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+15.27% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

1. aug 2025

Turustatistika

By TradingEconomics

Turukapital

57M

629M

Eelmine avamishind

20.92

Eelmine sulgemishind

21.39

Uudiste sentiment

By Acuity

78%

22%

357 / 380 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Fulgent Genetics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. juuni 2025, 20:45 UTC

Tulu

Broadcom 2Q Sales Climb on Booming AI Demand

5. juuni 2025, 23:45 UTC

Market Talk

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5. juuni 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Weak U.S. Data -- Market Talk

5. juuni 2025, 23:30 UTC

Market Talk

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5. juuni 2025, 21:32 UTC

Tulu

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. juuni 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. juuni 2025, 20:45 UTC

Tulu

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. juuni 2025, 20:24 UTC

Tulu

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Rev $15B >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Net $4.97B >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Adj EPS $1.58 >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q EPS $1.03 >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom Sees 3Q Rev $15.8B >AVGO

5. juuni 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5. juuni 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5. juuni 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5. juuni 2025, 19:22 UTC

Market Talk

Oil Futures Resume Upward Moves -- Market Talk

5. juuni 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5. juuni 2025, 18:32 UTC

Market Talk

Gold Slips After Trump-Xi Call -- Market Talk

5. juuni 2025, 18:26 UTC

Tulu

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5. juuni 2025, 18:06 UTC

Market Talk

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5. juuni 2025, 16:30 UTC

Omandamised, ülevõtmised, äriostud

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5. juuni 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. juuni 2025, 16:18 UTC

Market Talk

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5. juuni 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5. juuni 2025, 16:12 UTC

Market Talk

Global Energy Roundup: Market Talk

5. juuni 2025, 16:12 UTC

Market Talk

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5. juuni 2025, 16:03 UTC

Market Talk

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5. juuni 2025, 15:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Fulgent Genetics Inc Prognoos

Hinnasiht

By TipRanks

15.27% tõus

12 kuu keskmine prognoos

Keskmine 24 USD  15.27%

Kõrge 25 USD

Madal 23 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Fulgent Genetics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

1

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

17.32 / 19.04Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Neutral Evidence

Sentiment

By Acuity

357 / 380 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.